1 - 25 of 69 results for author:"Kaufman S." in Literature citations
Results Customize
› Repeat search in UniProtKB (25)
| Abnormal CX3CR1⁺ lamina propria myeloid cells from intestinal transplant recipients with NOD2 mutations. Lough D., Abdo J., Guerra-Castro J.F., Matsumoto C., Kaufman S., Shetty K., Kwon Y.K., Zasloff M., Fishbein T.M. Am. J. Transplant. 12:992-1003(2012) · Mapped (1) |
| beta1D chain increases alpha7beta1 integrin and laminin and protects against sarcolemmal damage in mdx mice. Liu J., Milner D.J., Boppart M.D., Ross R.S., Kaufman S.J. Hum. Mol. Genet. 21:1592-1603(2012) · Mapped (18) |
| NSAID-based gamma-secretase modulators do not bind to the amyloid-beta polypeptide. Barrett P.J., Sanders C.R., Kaufman S.A., Michelsen K., Jordan J.B. Biochemistry 50:10328-10342(2011) · Mapped (10) |
| A volumetric method for quantifying atherosclerosis in mice by using microCT: comparison to en face. Lloyd D.J., Helmering J., Kaufman S.A., Turk J., Silva M., Vasquez S., Weinstein D., Johnston B., Hale C., Veniant M.M. PLoS ONE 6:e18800-e18800(2011) · Mapped (15) |
| Activation of AKT signaling promotes cell growth and survival in alpha7beta1 integrin-mediated alleviation of muscular dystrophy. Boppart M.D., Burkin D.J., Kaufman S.J. Biochim. Biophys. Acta 1812:439-446(2011) · Mapped (19) |
| Identification and structure-activity relationship of 2-morpholino 6-(3-hydroxyphenyl) pyrimidines, a class of potent and selective PI3 kinase inhibitors. Pecchi S., Renhowe P.A., Taylor C., Kaufman S., Merritt H., Wiesmann M., Shoemaker K.R., Knapp M.S., Ornelas E., Hendrickson T.F. et al. Bioorg. Med. Chem. Lett. 20:6895-6898(2010) · Mapped (1) |
| Constriction of rat extra-splenic veins to lipopolysaccharide involves endothelin-1. Mansart A., Ruff L.J., Ariaans M.P., Ross J.J., Reilly C.S., Brown N.J., Kaufman S., Brookes Z.L. Naunyn Schmiedebergs Arch. Pharmacol. 381:555-562(2010) · Mapped (3) |
| Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells. Sinclair A.M., Coxon A., McCaffery I., Kaufman S., Paweletz K., Liu L., Busse L., Swift S., Elliott S., Begley C.G. Blood 115:4264-4272(2010) · Mapped (1) |
| Novel insights about class 2 integrons from experimental and genomic epidemiology. Ramirez M.S., Pineiro S., Centron D., Kaufman S., Kovensky J., Vay C., Tokumoto M., Fernandez A., Famiglietti A., Couto E. et al. Antimicrob. Agents Chemother. 54:699-706(2010) · UniProtKB (24) |
| Recombinant plant gamma carbonic anhydrase homotrimers bind inorganic carbon. Martin V., Villarreal F., Miras I., Navaza A., Haouz A., Gonzalez-Lebrero R.M., Kaufman S.B., Zabaleta E. FEBS Lett. 583:3425-3430(2009) · UniProtKB (1) |
| Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy. Gurpur P.B., Liu J., Burkin D.J., Kaufman S.J. Am. J. Pathol. 174:999-1008(2009) · Mapped (18) |
| Genetically determined proteolytic cleavage modulates alpha7beta1 integrin function. Liu J., Gurpur P.B., Kaufman S.J. J. Biol. Chem. 283:35668-35678(2008) · UniProtKB (3) · Mapped (6) |
| Exercise promotes alpha7 integrin gene transcription and protection of skeletal muscle. Boppart M.D., Volker S.E., Alexander N., Burkin D.J., Kaufman S.J. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295:R1623-30(2008) · Mapped (4) |
| The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis. Llovera R.E., de Tullio M., Alonso L.G., Leissring M.A., Kaufman S.B., Roher A.E., de Prat Gay G., Morelli L., Castano E.M. J. Biol. Chem. 283:17039-17048(2008) · Mapped (15) |
| Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. Elsherif L., Huang M.S., Shai S.Y., Yang Y., Li R.Y., Chun J., Mekany M.A., Chu A.L., Kaufman S.J., Ross R.S. Circ. Res. 102:1109-1117(2008) · Mapped (26) |
| Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation. Harmange J.C., Weiss M.M., Germain J., Polverino A.J., Borg G., Bready J., Chen D., Choquette D., Coxon A., DeMelfi T. et al. J. Med. Chem. 51:1649-1667(2008) · Mapped (1) |
| Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors. Weiss M.M., Harmange J.C., Polverino A.J., Bauer D., Berry L., Berry V., Borg G., Bready J., Chen D., Choquette D. et al. J. Med. Chem. 51:1668-1680(2008) · Mapped (1) |
| Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr. Lloyd D.J., McCormick J., Helmering J., Kim K.W., Wang M., Fordstrom P., Kaufman S.A., Lindberg R.A., Veniant M.M. Am. J. Physiol. Endocrinol. Metab. 294:E496-505(2008) · Mapped (28) |
| Increasing alpha 7 beta 1-integrin promotes muscle cell proliferation, adhesion, and resistance to apoptosis without changing gene expression. Liu J., Burkin D.J., Kaufman S.J. Am. J. Physiol., Cell Physiol. 294:C627-40(2008) · Mapped (4) |
| Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors. Potashman M.H., Bready J., Coxon A., DeMelfi T.M. Jr., DiPietro L., Doerr N., Elbaum D., Estrada J., Gallant P., Germain J. et al. J. Med. Chem. 50:4351-4373(2007) · Mapped (1) |
| Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer. Paulson K.E., Rieger-Christ K., McDevitt M.A., Kuperwasser C., Kim J., Unanue V.E., Zhang X., Hu M., Ruthazer R., Berasi S.P. et al. Cancer Res. 67:6136-6145(2007) · Mapped (4) |
| Alpha7beta1 integrin is a receptor for laminin-2 on Schwann cells. Chernousov M.A., Kaufman S.J., Stahl R.C., Rothblum K., Carey D.J. |
| Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy. Hanft L.M., Bogan D.J., Mayer U., Kaufman S.J., Kornegay J.N., Ervasti J.M. Neuromuscul. Disord. 17:569-574(2007) · Mapped (36) |
| Alpha7beta1 integrin does not alleviate disease in a mouse model of limb girdle muscular dystrophy type 2F. Milner D.J., Kaufman S.J. Am. J. Pathol. 170:609-619(2007) · Mapped (3) |
| Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies. Lin X., Murray J.M., Rico A.C., Wang M.X., Chu D.T., Zhou Y., Del Rosario M., Kaufman S., Ma S., Fang E. et al. Bioorg. Med. Chem. Lett. 16:4163-4168(2006) · UniProtKB (1) |